A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Clinical trial NCT04458857 · COMPLETED
Trial details
- NCT number
- NCT04458857
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-15
- Primary completion
- 2024-03-13
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.